Ashley B Grossman Selected Research

Adrenalectomy

3/2021	Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.
6/2018	A prospective longitudinal study of Pasireotide in Nelson's syndrome.
9/2016	Do patients with incidentally discovered bilateral adrenal nodules represent an early form of ARMC5-mediated bilateral macronodular hyperplasia?
7/2014	Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling.
11/2012	Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling.
2/2012	A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism.
11/2006	Cushing's syndrome caused by an occult source: difficulties in diagnosis and management.
2/2006	The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashley B Grossman Research Topics

Disease

61	Neoplasms (Cancer) 04/2024 - 01/2002
34	Pituitary Neoplasms (Pituitary Adenoma) 03/2021 - 01/2002
30	Cushing Syndrome 01/2022 - 11/2003
16	Paraganglioma (Paragangliomas) 04/2024 - 04/2004
16	Pituitary ACTH Hypersecretion 01/2022 - 01/2003
15	Pheochromocytoma 04/2024 - 02/2007
15	Adenoma (Adenomas) 01/2024 - 01/2002
11	Carcinoid Tumor (Carcinoid) 10/2022 - 02/2006
11	Carcinogenesis 04/2013 - 01/2002
10	Acromegaly 04/2024 - 09/2003
10	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 04/2004
9	Hypertension (High Blood Pressure) 01/2024 - 01/2009
8	Thyroid Neoplasms (Thyroid Cancer) 04/2021 - 07/2004
7	ACTH-Secreting Pituitary Adenoma 12/2021 - 06/2002
7	Obesity 07/2021 - 08/2002
6	Carcinoma (Carcinomatosis) 01/2024 - 06/2002
6	Prolactinoma (Prolactinomas) 07/2021 - 12/2008
6	Insulinoma 03/2013 - 12/2006
6	Insulin Resistance 04/2009 - 08/2002
5	Hypothyroidism 01/2020 - 01/2004
4	Hyperplasia 01/2024 - 07/2005
4	Neoplasm Metastasis (Metastasis) 12/2023 - 04/2004
4	Hypopituitarism (Sheehan's Syndrome) 01/2020 - 06/2005
4	Growth Hormone-Secreting Pituitary Adenoma 12/2014 - 09/2003
4	Diabetes Insipidus 10/2014 - 06/2005
4	Type 2 Diabetes Mellitus (MODY) 11/2012 - 06/2007
4	Hepatocellular Carcinoma (Hepatoma) 08/2010 - 08/2004
4	Hyperinsulinism (Hyperinsulinemia) 03/2009 - 04/2004
3	Adrenocortical Carcinoma 01/2024 - 03/2010
3	Hyperparathyroidism 03/2022 - 02/2009
3	Multiple Endocrine Neoplasia Type 1 03/2022 - 07/2011
3	COVID-19 09/2021 - 01/2020
3	Familial Isolated Pituitary Adenoma 01/2020 - 08/2010
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2019 - 01/2009
3	Sepsis (Septicemia) 03/2016 - 11/2007
3	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2016 - 02/2009
3	Ectopic ACTH Syndrome 08/2012 - 11/2003
3	Hypoglycemia (Reactive Hypoglycemia) 03/2009 - 07/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2008 - 07/2006
2	Adrenal Gland Neoplasms (Adrenal Cancer) 01/2024 - 05/2011
2	Disease Progression 11/2023 - 10/2008
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2023 - 07/2014
2	medullary Thyroid cancer 11/2021 - 01/2009

Drug/Important Bio-Agent (IBA)

30	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 11/2003
18	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2024 - 04/2003
16	GlucocorticoidsIBA 01/2020 - 06/2003
15	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2002
14	Hormones (Hormone)IBA 01/2021 - 01/2004
10	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2022 - 06/2004
9	aryl hydrocarbon receptor-interacting proteinIBA 01/2020 - 06/2008
8	Everolimus FDA Link 01/2024 - 01/2008
8	Insulin (Novolin)FDA Link 01/2022 - 08/2002
8	Messenger RNA (mRNA)IBA 07/2012 - 01/2002
8	GhrelinIBA 01/2010 - 08/2002
7	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2010
7	Growth Hormone (Somatotropin)IBA 01/2022 - 04/2003
7	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2002
7	pasireotideIBA 11/2019 - 08/2006
7	Octreotide (Sandostatin)FDA LinkGeneric 02/2018 - 08/2006
7	CatecholaminesIBA 01/2016 - 04/2004
6	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2023 - 04/2004
5	Radioisotopes (Radionuclides)IBA 11/2023 - 06/2004
5	Phosphotransferases (Kinase)IBA 11/2022 - 01/2004
5	Cabergoline FDA LinkGeneric 11/2019 - 05/2008
5	3-Iodobenzylguanidine (Iobenguane)IBA 08/2008 - 04/2004
4	Sunitinib (Sutent)FDA Link 11/2023 - 08/2010
4	CalciumIBA 01/2023 - 12/2008
4	Insulin-Like Growth Factor I (IGF-1)IBA 07/2022 - 09/2003
4	EnzymesIBA 01/2021 - 06/2008
3	pegvisomant FDA LinkGeneric 04/2024 - 11/2019
3	AlpelisibIBA 01/2024 - 11/2019
3	MicroRNAs (MicroRNA)IBA 03/2021 - 12/2011
3	Cadherins (E-Cadherin)IBA 11/2019 - 01/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2003
3	lanreotide (Somatuline)FDA Link 02/2018 - 03/2010
3	Dopamine Agonists (Dopamine Agonist)IBA 01/2016 - 05/2008
3	MineralocorticoidsIBA 11/2012 - 11/2006
3	AMP-Activated Protein KinasesIBA 01/2010 - 01/2008
3	Cyclin-Dependent Kinase Inhibitor p27IBA 02/2009 - 01/2002
3	ProlactinIBA 12/2008 - 12/2003
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2008 - 06/2003
2	CannabinoidsIBA 04/2024 - 07/2005
2	PotassiumIBA 01/2024 - 03/2022
2	SodiumIBA 01/2024 - 09/2021
2	AldosteroneIBA 01/2024 - 07/2014
2	ReninIBA 01/2024 - 06/2017
2	Mitotane (Lysodren)FDA Link 01/2024 - 03/2010
2	Calcium Gluconate (CBG)IBA 01/2024 - 03/2010
2	Parathyroid Hormone (Parathormone)IBA 01/2023 - 03/2022
2	somatostatin receptor 2IBA 01/2023 - 11/2019
2	Insulin-Like PeptidesIBA 07/2022 - 07/2013
2	Peptide Receptors (Peptide Receptor)IBA 11/2021 - 01/2021
2	Peptides (Polypeptides)IBA 07/2021 - 01/2009
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2021 - 04/2012

Therapy/Procedure

47	Therapeutics 04/2024 - 04/2003
10	Radiotherapy 04/2024 - 01/2003
9	Drug Therapy (Chemotherapy) 11/2023 - 06/2004
8	Adrenalectomy 03/2021 - 02/2006
4	Molecular Targeted Therapy 11/2022 - 03/2012
2	Aftercare (After-Treatment) 04/2024 - 04/2016